Literature DB >> 15276412

A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.

H Vasken Aposhian1, Robert A Zakharyan, Mihaela D Avram, Adriana Sampayo-Reyes, Michael L Wollenberg.   

Abstract

This laboratory has studied the enzymology involved in the biotransformation of inorganic arsenic to dimethylarsinous acid (DMA(III)) and in human studies established that monomethylarsonous acid (MMA(III)) and DMA(III) appear in urine of people chronically exposed to arsenic. It appears that only two proteins are required for inorganic arsenic biotransformation in the human, namely, monomethylarsonic acid (MMA(V)) reductase and arsenic methyltransferase. MMA(V) reductase and the unique glutathione transferase omega (hGST-O) are identical proteins. Arsenicals with a +3 oxidation state are more toxic than the +5 species. While methylation of arsenite, MMA(III), and DMA(III) produces less toxic +5 oxidation arsenic species containing an additional methyl group such as MMA(V), dimethylarsinic acid (DMA(V)), and TMAO, a new mechanism involving hydrogen peroxide for detoxifying arsenite, MMA(III), and DMA(III) is proposed based on in vitro experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276412     DOI: 10.1016/j.taap.2003.10.027

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  34 in total

1.  Crystal structure of the flavoprotein ArsH from Sinorhizobium meliloti.

Authors:  Jun Ye; Hung-Chi Yang; Barry P Rosen; Hiranmoy Bhattacharjee
Journal:  FEBS Lett       Date:  2007-07-25       Impact factor: 4.124

2.  Metals in proteins: cluster analysis studies.

Authors:  Juan A C Tamames; Maria João Ramos
Journal:  J Mol Model       Date:  2010-05-21       Impact factor: 1.810

3.  Bioaccumulation and biotransformation of arsenic compounds in Hediste diversicolor (Muller 1776) after exposure to spiked sediments.

Authors:  Andrea Gaion; Davide Sartori; Alice Scuderi; Daniele Fattorini
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-24       Impact factor: 4.223

4.  Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China.

Authors:  Shuhua Xi; Quanmei Zheng; Qiang Zhang; Guifan Sun
Journal:  Int Arch Occup Environ Health       Date:  2010-12-04       Impact factor: 3.015

5.  Transplacental arsenic carcinogenesis in mice.

Authors:  Michael P Waalkes; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

6.  Accumulation, biotransformation, and biochemical responses after exposure to arsenite and arsenate in the estuarine polychaete Laeonereis acuta (Nereididae).

Authors:  Juliane Ventura-Lima; Patrícia Baptista Ramos; Daniele Fattorini; Francesco Regoli; Luis Ferraz; Leandro Machado de Carvalho; José M Monserrat
Journal:  Environ Sci Pollut Res Int       Date:  2011-03-08       Impact factor: 4.223

7.  Arsenic Exposure in Relation to Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Cari L Tsinovoi; Pengcheng Xun; Leslie A McClure; Vivian M O Carioni; John D Brockman; Jianwen Cai; Eliseo Guallar; Mary Cushman; Frederick W Unverzagt; Virginia J Howard; Ka He
Journal:  Stroke       Date:  2017-12-06       Impact factor: 7.914

8.  Studies on exposure status of inhabitants to water-arsenic valence states in areas with endemic arsenism in the Datong basin in Shanxi.

Authors:  Jun Li; Xiaotian Cheng; Zhenghui Wang; Xinping Wen; Lingling Han; Zhiping Sang; Jie Zhang; Hushun Duan; Binfeng Liang; Jianguo Gao
Journal:  Front Med China       Date:  2007-05

9.  Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population.

Authors:  Yuan-yuan Xu; Yi Wang; Xin Li; Miao He; Peng Xue; Jing-qi Fu; Hui-hui Wang; Gui-fan Sun
Journal:  Int Arch Occup Environ Health       Date:  2008-05-15       Impact factor: 3.015

10.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.